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Summary
 
The major histocompatibility complex (MHC) class Ib molecule H2-M3 binds 
 
N
 
-formylated
peptides from mitochondria and bacteria. To explore the role of M3 expression and peptide sup-
ply in positive and negative selection, we generated transgenic mice expressing an M3-restricted
TCR-
 
a
 
/
 
b
 
 from a CD8
 
1
 
 T cell hybridoma (D7) specific for a listerial peptide (LemA). Devel-
opment of M3-restricted transgenic T cells is impaired in both 
 
b
 
2-microglobulin–deficient and
transporter associated with antigen processing (TAP)-deficient mice, but is not diminished by
changes in the 
 
H-2
 
 haplotype. Maturation of M3/LemA-specific CD8
 
1
 
 single positive cells in
fetal thymic organ culture was sensitive to M3 expression levels as determined by antibody
 
blocking and use of the 
 
castaneus
 
 mutant allele of M3. Positive selection was rescued in TAP
 
2
 
/
 
2
 
lobes by nonagonist mitochondrial and bacterial peptides, whereas LemA and a partial agonist
variant caused negative selection. Thus, M3-restricted CD8
 
1
 
 T cells are positively and nega-
tively selected by M3, with no contribution from the more abundant class Ia molecules. These
results demonstrate that class Ib molecules can function in thymic education like class Ia mole-
cules, despite limited ligand diversity and low levels of expression.
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T
 
he repertoire of CD8
 
1
 
 T cells is shaped by both posi-
tive and negative selection in the thymus. Results from
fetal thymic organ culture (FTOC)
 
1
 
 in both 
 
b
 
2-microglob-
ulin (
 
b
 
2m)– and transporter associated with antigen pro-
cessing (TAP)-deficient mice showed that both of these
selection processes involve the recognition of self-peptide–
MHC class I complexes by T cell receptors expressed on
double-positive thymocytes (1, 2). A key factor that deter-
mines the fate of thymocytes is the avidity and affinity of
the TCR–ligand interaction (3–7). Strong TCR peptide–
MHC interactions lead to negative selection, and weak
TCR peptide–MHC interactions lead to positive selection.
Since both types of selection can be mediated by the same
MHC molecule, the MHC-bound peptides are believed to
play an important role in dictating the outcome of the se-
lection process. Several studies showed that a degree of de-
generacy exists between TCR peptide–MHC interactions
during positive selection, suggesting that this type of flexi-
bility might be required to generate a diverse T cell reper-
toire (8–10). Negative selection requirements appear more
stringent, requiring antigenic or partial agonist peptides
with only minor differences from the antigenic peptide (6).
Studies on the selection of CD8
 
1
 
 T cells thus far have
focused on class Ia–restricted T cells. However, little is known
about the selection requirements of class Ib–restricted T
cells. Class Ib molecules are less polymorphic and have
lower expression levels than class Ia molecules. The peptide-
binding specificities of class Ib molecules H2-M3, Qa-1, and
HLA-E have been found to be more constrained than
those of class Ia molecules (11–16). These properties may
affect the contribution of class Ib molecules to thymic edu-
cation. To explore this question, we generated transgenic
mice expressing TCR-
 
a
 
/
 
b
 
 restricted by H2-M3, a class Ib
molecule with unique specificity for hydrophobic 
 
N
 
-formy-
lated peptides.
M3 presents 
 
N
 
-formylated peptides from bacteria and
 
1
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b
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b
 
2-micro-
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castaneus
 
; ES, embry-
onic stem; FTOC, fetal thymic organ culture; IF, immunofluorescence;
SP, single positive; TAP, transporter associated with antigen processing;
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mitochondria to CD8
 
1
 
 CTLs (17, 18). M3 is nonpolymor-
phic in most strains of mice, and thus may have evolved to
present this class of peptides, which are not presented by
class Ia molecules (19). M3 was originally identified as the
MHC molecule that presents allelic forms of the maternally
transmitted factor (MTF) peptide, which is encoded at the
NH
 
2
 
 terminus of the mitochondrial 
 
ND1
 
 gene (20–22).
Subsequently, an allelic variant of the mitochondrial 
 
COI
 
gene was also found to be presented as a minor histocom-
patibility antigen by M3 (23). Additionally, M3 has been
found to present three peptides from the intracellular
pathogen 
 
Listeria monocytogenes
 
, namely LemA (fMIGWII
[24, 25]), Fr38 (fMIVIL [26]), and fMIVTLF (27). Adoptive
transfer of M3-restricted, 
 
Listeria
 
-specific CTLs protects ani-
mals from infection, suggesting that M3 plays an important
role in the host defense against intracellular bacteria (28).
M3 is encoded at the telomeric end of the mouse 
 
H-2
 
complex, and shares many conserved features with class Ia
molecules, including interaction with CD8 (22, 29). 
 
M3
 
message can be detected in most adult tissues and during
early embryonic development, although at much lower
levels than class Ia molecules (30). We have recently shown
that the majority of M3 is retained intracellularly because of
a lack of endogenous antigen supply (31). M3 is undetect-
able on the surface of thymocytes and thymic epithelial cell
lines by staining with a monoclonal reagent. However, sur-
face expression of M3 can be induced on antigen present-
ing cells by addition of exogenous 
 
N
 
-formylated peptides.
This expression pattern raises the question of the role of
M3 in thymic education. Can a molecule with such a low
level of expression contribute to selection of T cells re-
stricted by this molecule? Furthermore, because the pool of
endogenous mitochondrial peptides is limited both in
amount and diversity (13 sequences, only 2 of which bind
M3 with high affinity), M3-restricted T cells may have a
very low possibility of autoreactivity. This might lessen the
requirement for M3 to participate in negative selection.
In this study, we analyzed positive and negative selection
in TCR transgenic animals bearing the D7 TCR specific
for listerial peptide (LemA) in the context of M3. We show
that M3 is the primary selecting element for M3-restricted
T cells. Similar to class Ia-restricted T cells, positive selec-
tion and negative selection of M3-restricted T cells were
peptide dependent. The essential role of M3 in the selec-
tion of a subset of pathogen-specific T cells indicates that
MHC class Ib molecules play a significant role in T cell
repertoire development and, consequently, in defense
against microbial infection.
 
Materials and Methods
 
Cloning of D7 TCR Transgenic Constructs.
 
The following oli-
gonucleotides were used in reverse transcription PCR on cDNA
from clone CN.8 (28): V
 
a
 
10cass 5
 
9
 
-AACGTCGCAGCTC-
TTTGCAC-3
 
9
 
, V
 
b
 
5.2cass 5
 
9
 
-AAGGTGGAGAGAGACAAAGG-
ATTC-3
 
9
 
 (32), Alcon 5
 
9
 
-GATGTTTTACTGGTACACAG-3
 
9
 
,
and C
 
b
 
reverse 5
 
9
 
-TGTGCTTGGCCAGGGGTTCTT-3
 
9
 
. For
cloning of the full VDJ regions from D7 hybridoma genomic
 
DNA, the following primer pairs were used: V
 
a
 
10lead-XmaI
5
 
9
 
-GACCCGGGCTTCTCACTGCCTAGCCATGAAGAGC-
CTGCTGAGCTCTCTG-3
 
9
 
 and J
 
a
 
D7intron-NotI 5
 
9
 
-CTTA-
CGGCCGAGGAAGTACTGTCCTGAG-3
 
9
 
, and V
 
b
 
5.2lead-
XhoI 5
 
9
 
-CCAGCATCTCGAGAAGAAGCATGTCTAAC-3
 
9
 
and J
 
b
 
2.2intron-SacII 5
 
9
 
-GATGCCGCGGAGCTGTCCTGCT-
CTGAATATCTTC-3
 
9
 
. The amplified D7 TCR-
 
a
 
 and -
 
b
 
 DNA
fragments were sequenced and cloned into the XmaI and NotI sites
in TCR-
 
a
 
cass, and into the XhoI and SacII sites in TCR-
 
b
 
cass
(TCR cassette vectors were provided by Drs. C. Benoist and D.
Mathis, Harvard Medical School, Boston, MA [33]).
 
Generation of M3-restricted LemA-specific TCR Transgenic Mice
(D7 Tg).
 
The 
 
a
 
 and 
 
b
 
 TCR transgenic constructs were co-
transfected with the neomycin resistance plasmid (pPNT-neo)
into R1 embryonic stem (ES) cells (strain 129) by electropora-
tion, as described previously (34). Transfected cells were selected
by G418, and the TCR-
 
a
 
 and -
 
b
 
 transgenes were detected by PCR
using V
 
a
 
10lead-XmaI and J
 
a
 
D7intron-NotI, and V
 
b
 
5.2cas and
J
 
b
 
2.2intron-SacII. Presence of both transgenes was confirmed by
Southern blot with probes for the constant regions of TCR-
 
a
 
(35) and TCR-
 
b
 
 (36) on HindIII– or EcoRI-digested genomic
DNA, respectively. ES cells containing both TCR-
 
a
 
 and -
 
b
 
transgenes were injected into C57BL/6 (B6) blastocysts to gener-
ate chimeric mice at the Gwen Knapp Center Transgenic Facil-
ity. Chimeric mice that contained high levels of V
 
b
 
5
 
1
 
Ly9.1
 
1
 
cells in PBL were chosen as founders and bred with B6 mice to
produce transgene-positive offspring. Three lines of transgenic
mice were established. The development of the transgenic T cells
in these three lines of mice is quite similar. Therefore, only one
transgenic line was used for further breeding.
 
Mice.
 
B6, B10.D2, 
 
b
 
2m
 
2
 
/
 
2
 
, TAP
 
2
 
/
 
2
 
, and TCR-
 
a
 
2
 
/
 
2
 
 mice
were purchased from The Jackson Laboratory. B6.CAS3(R9)
(B6.R9)—carrying a haplotype with 
 
H2-K
 
 through 
 
H2-D
 
 from
B6 and the rest of 
 
H2
 
, including M3, from 
 
Mus musculus castaneus
 
(cas3)—was provided by Dr. Kirsten Fischer Lindahl (University
of Texas, Southwestern Medical Center, Dallas, TX). Mice were
housed in the conventional animal facility or in the barrier facility
of the University of Chicago. During backcrosses, animals were
typed for transgene by expression of V
 
b
 
5 on CD8
 
1
 
 PBLs. Where
V
 
b
 
5 expression was minimal, PCR of D7 
 
a
 
 and 
 
b
 
 chains was
performed as stated for ES cell typing. Changes in haplotype, as
well as loss of functional 
 
b
 
2m or TAP, were detected by loss of
staining with FITC–anti-K
 
b
 
. TCR-
 
a
 
2
 
/
 
2
 
 status was assessed by
expression of endogenous V
 
a
 
2 on TCR-
 
a
 
/
 
b
 
1
 
 PBLs, and con-
firmed by Southern blot analysis of HindIII-digested genomic
DNA with a probe for the TCR C
 
a
 
 region. To type D7
 
1
 
B6.R9
animals, PBLs were incubated with 10 
 
m
 
M of LemA peptide for
4 h at 37
 
8
 
C, and stained for M3 surface expression by anti-M3
mAb (mAb130).
FTOCs. Fetal thymi were cultured according to procedures
described by Ashton-Rickardt et al. (1). In brief, thymic lobes from
gestational day 16.5 fetal mice were placed onto nitrocellulose fil-
ters (Millipore Corp.). Filters were placed in 2-cm-diameter
dishes, then incubated for 10 d at 378C in RPMI 1640 medium
containing 10% fetal bovine serum (HyClone), 2 mM l-gluta-
mine, 20 mM Hepes, 50 mM 2-ME, nonessential amino acids,
sodium pyruvate, penicillin, and streptomycin (RPMI-10). The
peptide and media were replenished every day where indicated.
Abs, M3-LemA Tetramer, and Peptides. The following mAbs
were purchased from PharMingen: FITC–anti-CD8a, PE–anti-
CD8a, PE–anti-Va2, CyChrome–anti-CD4, FITC–anti-Vb5,
FITC–anti-Kb, FITC–anti-IAb, biotin–anti-Ly9.1, and biotin–
mouse anti–hamster IgG. Y3, anti-Kb; and B22, anti-Db were1871 Chiu et al.
purchased from American Type Culture Collection. PE–M3-
LemA tetramer and allophycocyanin–M3-LemA tetramer were
prepared as described previously (37). mAb130 was purified as
described previously (38). Synthetic peptides were purchased
from Research Genetics. Peptide sequences were as follows:
LemA, fMIGWII; LemA5I®A, fMIGWAI; LemA6I®A, fMIG-
WAI; Fr38, fMIVIL; ND1, fMFFINIL; ND4, fMLKIILP; and
COI, fMFINRWLFS. All peptides were .90% pure as deter-
mined by mass spectrometry. Peptides were dissolved in DMSO
at concentrations of 1–20 mM.
Cell Preparations and Flow Cytometric Analysis. Thymocyte sus-
pensions were prepared from cultured fetal thymi by mechanical
desegregation in RPMI-10 media, and stained in immunofluo-
rescence (IF) buffer (HBSS containing 2% fetal bovine serum and
0.1% NaN3) using combinations of fluorescent-conjugated Abs
for 30 min at 48C. When staining involved M3-LemA tetramer,
incubation time was extended to 1 h. The stained cells were ana-
lyzed by flow cytometry using a FACSCalibur™ (Becton Dick-
inson) with the CELLQuest™ software. Thymic stromal cell sus-
pensions were prepared by digesting fetal thymi in 0.1% trypsin,
0.5 mM EDTA for 40 min at 378C. Digestion was stopped by
addition of IF buffer. After mechanical disruption of the lobe,
cells were harvested and washed two times with IF buffer before
cell surface staining experiments (10). Cells were stained with
anti-M3 mAb (130) followed by biotinylated mouse anti–hamster
IgG, and a third incubation with streptavidin-conjugated PE and
FITC-anti–I-Ab. Staining with each reagent was performed for
30 min on ice in IF, followed by washing with the same buffer.
The expression of M3 on I-Ab–positive thymic stromal cells was
analyzed by FACS®.
CTL Assays. CTL effectors were established by culturing
splenocytes of D71TCR-a2/2 mice at 5 3 106 cells/ml in
RPMI-10 with 5 mM of LemA peptide for 3 d at 378C. 1 3 106
target cells were incubated in RPMI-10 with or without 1 mM
of LemA peptides for 18–20 h. Cells were washed free of excess
peptide and labeled with 100 mCi [51Cr]sodium chromate for 1 h
at 378C. Target cells (1 3 104 cells) were added to round-bot-
tomed microtiter wells containing effector cells. After 4 h incuba-
tion at 378C, 100 ml of supernatant from each well was removed
and assayed for 51Cr release. Percent specific lysis 5 (experimen-
tal 2 spontaneous release) 3 100/(maximal release 2 spontane-
ous release). Limiting dilution analysis for CTL precursor fre-
quency was performed on fetal thymic lobes after 10 d of culture.
Four or five lobes from each treatment were pooled, and thymo-
cytes were diluted to concentrations between 10,000 and 3 cells
per well and incubated with 1 3 106 irradiated B6 stimulators per
well, 10 U/ml IL-2, and 5 mM LemA peptide. Peptide was re-
plenished at days 3 and 6. On day 7, 51Cr-labeled LemA-coated
L929 targets were added at 1 3 104 per well, and 51Cr release was
measured after 4 h.
Cytokine Assay. Splenocytes from D71 mice (5 3 105 cells per
well) were cultured in round-bottomed microtiter wells in a final
volume of 200 ml of RPMI-10, with 10 mM of various peptides.
After 48 h, the culture supernatants were harvested and the levels
of IFN-g were quantitated by sandwich ELISA (PharMingen).
Results
Generation of Transgenic Mice Expressing an M3-LemA–spe-
cific TCR. The D7 hybridoma generated from CTL clone
CN.8 was chosen for the construction of TCR transgenic
mice (25, 28). This CTL is CD81 and specific for a listerial
peptide, LemA (f-MIGWII), in the context of M3, and can
confer protection from infection by adoptive transfer. Leader
and J-C intron primers were designed and used to clone the
entire coding sequence (Va10.2JaD7 and Vb5.2Jb2.2) from
D7 hybridoma DNA into the TCR cassette vectors (33).
Three lines of D7 transgenic mice were generated and bred
onto the B6 background. Lymphocytes isolated from thymus,
spleen, and lymph nodes of D7 transgenic mice were stained
with FITC–anti-CD8, PE–anti-CD4, and APC–M3-LemA
tetramer to examine the development of D71 T cells. FACS®
analysis showed that D71 T cells (M3-LemA tetramer posi-
tive) are highly enriched in the CD8 lineage (Fig. 1 A).
Compared with nontransgenic controls, the transgenic mice
showed an increase in percentage of D71CD81 cells (4-fold
in thymus, 20-fold in spleen, and 18-fold in lymph node).
Splenocytes from transgenic animals were evaluated
against nontransgenic littermates for antigen-specific re-
sponses against the hexameric LemA peptide. Nontrans-
genic splenocytes showed no reactivity to LemA peptide
(data not shown). Splenocytes from D7 animals developed
into M3-restricted, LemA-specific CTLs after 3 d in cul-
ture with LemA peptide. D7 CTLs specifically lysed
LemA-coated L929 targets bearing the wild-type M3 allele
(M3wt) (Fig. 1 B). B10.CAS2 fibroblasts express a mutant casta-
neus allele of M3 (M3cas) that does not present N-formylated
peptides efficiently. LemA-coated B10.CAS2 targets were
only slightly susceptible to lysis, whereas an M3wt transfectant
of B10.CAS2 (TR8.4a) was recognized as efficiently as the
L929 targets. These data suggest that D7 transgenic T cells
preserve functional capacities and antigenic specificity of
the original T cell clone.
Development of D71 T Cells Is MHC Unrestricted and TAP
and b2m Dependent. Because M3 is nonpolymorphic and
expressed at low levels, it is possible that M3-restricted T cells
are selected on the more abundant class Ia molecules H-2K,
D, or L. We bred the D7 transgenes onto the B10.D2 back-
ground which bears the H-2d class Ia molecules to see if
the selection and development of M3-restricted T cells was
dependent on a particular class Ia allele. Staining with M3-
LemA tetramers showed that D71CD81 T cell develop-
ment is unimpaired in the B10.D2 background (Fig. 2 A).
To eliminate the possibility that class Ia interaction with
endogenous a chains contributes to positive selection, we
bred the transgene onto the TCR-a2/2 background. The
CD81 population in D71TCR-a2/2 mice is exclusively
positive for M3-LemA tetramer staining (Fig. 2 B), show-
ing that the D7 TCR is sufficient for selection. The devel-
opment of transgenic T cells is impaired in TCR-a2/2
TAP2/2 and b2m2/2 mice (Fig. 2 B). These data suggest
that the selection and development of D71 T cells re-
quires the presentation of peptide on a class I molecule.
Both TAP and b2m have been shown to be important for
the expression of M3 on the cell surface (31, 39, 40).
M3 Expression Is Required for Development of D71CD81
Single Positive Thymocytes. The lack of H-2 restriction and
the TAP and b2m dependence of D71 T cell development
suggested that M3 expression might be required for posi-
tive selection. We analyzed the selection of the D71 T cells1872 Thymic Selection of M3-restricted T Cells
in FTOC in order to manipulate TCR access to M3 with
an mAb (mAb130) that blocks M3-restricted CTL re-
sponses (31). Fetal thymic lobes were harvested from gesta-
tional day 16.5 D71TCR-a2/2 animals, and incubated ei-
ther with anti-M3 or a control hamster Ab at 50 mg/ml for
10 d. Additional lobes were incubated with anti–class Ia
Abs or a control mouse Ab. Fig. 3 shows representative re-
duction in the percentage of CD81 single positive (CD8sp)
thymocytes in anti-M3–treated lobes. The average percent
reduction was z80% (from average 20% reduced to 4%).
Treatment with Ab to class Ia molecules had no effect, in
agreement with our data for D71 T cell development in
different H-2 haplotypes. CD8sp thymocytes expressed Vb5
at high levels (data not shown), which is indicative of anti-
gen specificity in the TCR-a2/2 background.
D71 T Cells Are Inefficiently Selected on an M3cas Allele.
We bred the D7 transgene onto an H-2 recombinant back-
ground B6.R9, which expresses M3cas, to detect any effect
of reduced M3 expression on thymic development. The
castaneus allele of M3 contains an amino acid substitution
(Leu95®Gln) that results in reduced recognition by M3-
specific CTLs (30). This substitution might affect M3 sur-
face expression, as we were unable to detect M3 by IF
staining on the surface of B6.R9 splenocytes (data not
shown). Fig. 4 shows the relative efficacy of M3wt (B6) and
M3cas (B6.R9) in selection of D71 T cells. In FTOC of
D71 B6 lobes, antigen-specific CD8sp thymocytes account
for 13.4% of total thymocytes (57.8% of 23.2%). In com-
parison, D71 B6.R9 lobes have a reduced total percentage
of CD8sp cells (11.5%), and only a minor proportion of
these cells are antigen specific (15.9%). Thus, the total per-
centage of D71CD8sp thymocytes in the B6.R9 back-
ground is reduced by z85% (from 13.4 to 1.8%). The per-
centage of D71CD8sp thymocytes in the B6.R9 thymic
lobes is reduced when anti-M3 Ab is present during FTOC
(66 6 16% reduction, n 5 6; data not shown). This indi-
cates that the small percentage of D71CD8sp cells in the
Figure 1. D7 transgenic mice develop increased numbers of CD81 cells
that are M3 restricted and LemA specific. (A) Thymus, spleen, and lymph
node cells from nontransgenic (D7Tg2) and D7 transgenic (D7Tg1) B6 an-
imals were stained with FITC–anti-CD8 and APC–M3-LemA tetramers.
Percentages of D7 TCR1 cells are indicated from a representative experi-
ment. (B) Splenocytes from D71TCRa2/2 mice were incubated at 5 3
106/ml with 1 mM LemA peptide for 3 d. Ficoll-purified effector cells were
tested for cytolytic activity against L929, B10.CAS2 fibroblasts, and an
M3wt transfectant (TR8.4a) in the presence (black bars) or absence (hatched
bars) of 1 mM LemA peptide at an E/T ratio of 10:1.
Figure 2. Development of D71 T cells is b2m and TAP dependent,
but MHC unrestricted. Splenocytes from wild-type (A) and mutant ani-
mals (B) of the indicated backgrounds were stained with FITC–anti-CD8
and with an APC-conjugated M3-LemA tetramer to assess development
of M3-LemA–specific T cells. The percentage of double positive cells is
indicated for each animal.1873 Chiu et al.
B6.R9 thymus develop in an M3-dependent manner, de-
spite the low level of expression of M3cas.
Positive Selection of the D7 TCR Is Induced by N-formylated
Peptides. M3 binds N-formylated peptides with 100–
1,000-fold greater affinity than nonformylated peptides (12).
Mitochondria are the only source of these peptides in mam-
malian cells. In a previous study, we showed that the mito-
chondrial peptides ND1 and COI bind M3 with higher af-
finity than the 11 remaining mitochondrial peptides (31).
We also found that Fr38, a peptide from Listeria monocytoge-
nes, which is not recognized by the D7 hybridoma, binds
M3 with high affinity. To determine whether these peptides
can induce increased surface expression of M3 on TAP2/2
thymic stromal cells, we cultured fetal thymic lobes from
TAP2/2 mice with or without 20 mM peptide for 10 d, and
harvested the cells to stain with anti–class II and anti-M3
Abs. Fig. 5 shows that ND1, COI, and Fr38 increase surface
expression of M3 on I-Ab1 thymic stromal cells from TAP2/2
mice. M3 expression is low on thymic stromal cells from B6
lobes as well (data not shown), staining at a similar level as
cells from DMSO-treated TAP2/2 thymi in the absence of
exogenous N-formylated peptide. The induced increase in
expression of M3 is similar for these three peptides.
Because of the ability of these N-formylated peptides to
stabilize surface expression of M3 on thymic stromal cells,
we analyzed the role of each peptide in positive selection.
Fig. 6 A shows representative staining of thymocytes devel-
oped in FTOC of D71TCR-a2/2TAP2/2 thymic lobes
incubated with or without 20 mM peptide for 10 d. Al-
though each peptide was able to stabilize surface expression
of M3, the increase in positive selection of CD8sp thy-
mocytes varied between peptides. Fig. 6 B displays the per-
centage increase in CD8sp thymocytes between pairs of
lobes from each animal. The average increase in CD8sp cells
was approximately twofold for ND1 (1.85 6 0.65, n 5 14)
and COI (1.78 6 0.60, n 5 20), and approximately three-
fold for Fr38 (2.86 6 1.15, n 5 16). ND4 is a mitochon-
drial peptide that binds to M3 weakly and is very inefficient
at stabilization of M3 on the cell surface. Incubation with
ND4 caused no increase in positive selection of transgenic
CD8sp thymocytes (1.05 6 0.31, n 5 6).
The ability of N-formylated peptides to increase develop-
ment of functional CTL precursors was assessed by a limiting
Figure 3. Development of D71 T cells in FTOC is M3 dependent.
Thymic lobes were harvested from gestational day 16.5 D71TCRa2/2
mice. One lobe from each animal was incubated with Ab against either
M3 or H-2Kb and H-2Db. The remaining lobe was incubated with an ap-
propriate control Ab. After 10 d, lobes were harvested and stained with
CyChrome–anti-CD4, PE–anti-CD8a, and FITC–anti-Vb5 to assess
maturation of CD8sp transgenic thymocytes. All CD8sp thymocytes were
Vb51. The average reduction in CD8sp generation after incubation with
anti-M3 was 70–85%. Ab against class Ia molecules had no effect. Results
are representative from a total of nine pairs of thymic lobes.
Figure 4. The M3cas allele does not efficiently select D71CD8sp thy-
mocytes. Gestational day 16.5 thymic lobes were harvested from D7
transgenic animals in either the B6 (M3wt) or B6.R9 (M3cas) backgrounds,
and incubated for 10 d to assess the development of D71 T cells on differ-
ent M3 alleles. Thymocytes were stained with PE–anti-CD4, FITC–anti-
CD8, and with APC–M3-LemA tetramer. The percentage of CD8sp cells
is reduced in the B6.R9 background (top). The surface expression of D71
TCR on gated CD8sp cells, detected by M3-LemA tetramer, was dis-
played as a histogram (bottom). The numbers represent the percentage of
CD8sp cells which are M3-LemA tetramer positive. Results are represen-
tative from two B6 thymic lobes and two B6.R9 lobes.
Figure 5. N-formylated peptide increases surface expression of M3 on
TAP2/2 thymic stromal cells. Gestational day 16.5 thymic lobes from
TAP2/2 animals were incubated with or without 20 mM peptide for 10 d.
Thymic stromal cells were harvested as described in Materials and Methods.
Cells were stained with FITC-anti–I-Ab and either anti-M3 or a control
hamster Ab, followed by biotinylated anti–hamster Ig and PE-streptavidin.
Histograms display the fluorescence intensity of staining with either anti-M3
(solid line) or the control Ab (dotted line) on I-Ab–positive cells.1874 Thymic Selection of M3-restricted T Cells
centage reduction in LemA6I®A treated lobes was z80% for
CD41CD81 double positive, and 20% for CD8sp (data not
shown). In contrast to LemA and LemA6I®A, the peptides
that promote positive selection (ND1, COI, and Fr38)
elicit no response from D71 T cells, even at 10 mM con-
centrations (Fig. 8). Thus, M3 is capable of effective nega-
tive selection even with weak agonist peptides.
Discussion
To determine whether MHC class Ib molecules can
contribute to thymic education in the same manner as class
Figure 6. D71CD8sp development is peptide dependent. (A) Thymic lobes from
D71TAP2/2TCRa2/2 mice were harvested on gestational day 16.5. One lobe from
each animal was incubated with 20 mM of the indicated N-formylated peptide from mi-
tochondria (ND1 and COI) or L. monocytogenes (Fr38). The matching lobe was incubated
with an appropriate concentration of solvent alone. After 10 d of culture, thymocytes
were stained with CyChrome–anti-CD4, PE–anti-CD8a, and FITC–anti-Vb5. All
CD8sp thymocytes were Vb5 positive. The plots are representative of experiments from
several animals, with the percentage of CD8sp thymocytes indicated. (B) Relative in-
crease in CD8sp cells was calculated for each pair of lobes as follows: % of CD8sp cells in
the peptide-treated lobe/% of CD8sp cells in the control lobe. Circles represent pairs of
thymic lobes, and the horizontal bar indicates the mean value. For ND1, n 5 14; for
COI, n 5 20; for Fr38, n 5 16; and for ND4, n 5 6. No significant differences in the total number of thymocytes were observed between peptide-
treated lobes and controls. (C) Increase in functional development in peptide treated lobes was calculated in a limiting dilution CTL development assay.
After 10 d of culture as above, four or five lobes were pooled, and thymocytes were diluted in series ranging from 10,000 to 3 cells per well and incu-
bated with B6 stimulators, IL-2, and LemA peptide. On day 7, 51Cr-labeled, LemA-coated RMA cells were used as targets for CTL assay. Percent in-
crease in CTL precursor (CTL p) frequency is calculated as follows: [(number of positive wells from peptide-treated lobes/number of positive wells from
the control lobes) 2 1] 3 100. Wells were considered positive if the total counts released were 3 SD above the spontaneous release value.
dilution assay. Thymocytes from peptide-treated lobes from
D71TCR-a2/2TAP2/2 animals were compared with the
control partner lobes. The pooled lobes from each group
were diluted to concentrations between 10,000 and 3 per
well and incubated with LemA peptide and irradiated stimu-
lators to allow the development of CTLs. Each peptide in-
duced at least a threefold increase in functional CTL precur-
sors (Fig. 6 C), indicating effective positive selection by two
mitochondrial peptides and one bacterial sequence.
Negative Selection Is Efficiently Mediated by M3. Because
of the low level of expression of M3 compared with class Ia
molecules, we sought to determine if negative selection
was effectively mediated by M3. Thymic lobes from D71
TCR-a2/2 mice were incubated with or without 20 mM
LemA peptide for 10 d, and cells were stained for CD4,
CD8, and either anti-Vb5 or M3-LemA binding. Both the
percentage of CD41CD81 double positive cells and the
percentage of CD8sp cells were significantly reduced (Fig.
7). Double positive cells were reduced by 70–85%, and
CD8sp cells were reduced by 40–60%. The remaining
CD8sp cells in peptide-treated lobes had reduced TCR ex-
pression as assessed by either Vb5 staining or M3-LemA
staining (data not shown). In addition, total cell counts were
also reduced in peptide-treated lobes (2.4 6 0.23 3 105
cells/lobe without peptide, 1.2 6 0.3 3 105 cells/lobe with
20 mM LemA). A similar effect was observed when lobes were
incubated with a LemA variant (LemA6I®A, fMIGWIA), a
weak agonist which stimulates D71 T cells minimally. Per-
Figure 7. M3 efficiently mediates negative selection. Gestational day
16.5 thymic lobes from D71TCRa2/2 mice were harvested and incu-
bated in the presence or absence of 20 mM LemA peptide. After 10 d,
thymocytes were stained with CyChrome–anti-CD4, PE–anti-CD8, and
FITC–anti-Vb5. Percentages are indicated in quadrants. Results are rep-
resentative from a total of four pairs of thymic lobes.1875 Chiu et al.
Ia molecules, we analyzed positive and negative selection in
TCR transgenic animals bearing the D7 TCR-a/b specific
for the listerial peptide LemA in the context of M3. M3
plays the dominant role in positive selection of the D7
TCR, as shown by the impaired development of transgenic
thymocytes in the presence of anti-M3 blocking Ab, or in
the presence of the castaneus mutant M3 allele. Although
selection was significantly diminished in the B6.R9 (M3cas)
background, incubation with anti-M3 Ab further reduced
the percentage of D71CD8sp thymocytes, suggesting that
M3cas is capable of selecting some D71 T cells. This is con-
sistent with the ability of B6.R9 animals to develop alloge-
neic responses against M3wt molecules (41, 42). No appar-
ent contribution is required from class Ia molecules, as
suggested by the development of transgenic T cells in an
MHC-unrestricted fashion. Peptide is required for positive
selection of D7 TCR, as shown by the differential rescue of
CD8sp development in TAP2/2 fetal thymic lobes by four
peptides from mitochondria and bacteria. The concentra-
tion of peptide (20 mM) used in these FTOCs increased the
surface expression of M3 on thymic stromal cells signifi-
cantly over background levels. Because of the hydropho-
bicity of M3-binding peptides, higher concentrations of
peptide caused precipitation. Negative selection is also me-
diated by addition of the antigenic peptide to TCR-a2/2
FTOCs. Thus, M3 is responsible for both positive and neg-
ative selection of M3-restricted T cells.
It is of interest that M3 is a potent positive selecting ele-
ment, despite surface expression levels in the thymus that
are undetectable by IF staining in wild-type animals (31).
Because M3 can bind only two mitochondrial peptides
with high affinity (31, 42), it is likely that the majority of
M3 molecules on the cell surface are occupied by these
ligands. The remaining mitochondrial ligands may also
contribute, depending on the balance of affinity and abun-
dance, which is currently unexplored. By comparison, the
pool of 105–106 class Ia molecules on each cell presents as
many as 103–104 different self-peptides (43). Although the
expression level of M3 is about one to two orders of mag-
nitude lower than that of class Ia molecules, the total num-
ber of identical M3 self-peptide complexes such as M3–
ND1 or M3–COI complexes may be comparable to the
number of any given class Ia–peptide complex, because of
the greater numbers of ligands competing for presentation
on class Ia molecules. A similar argument can be made in
comparing low levels of M3 in the wild-type animal to low
levels of class Ia in TAP2/2 animals. We have shown previ-
ously that M3 behaves in a wild-type background as a class
Ia molecule does in a TAP2/2 background because of a
limited supply of endogenous peptides. However, class Ia
molecules expressed at low levels in TAP2/2 animals are
not sufficient to support positive selection (1). It is possible
that even in the absence of TAP, the supply of peptides
available to class Ia molecules in the endoplasmic reticulum
still has sufficient diversity to dilute any particular MHC–
peptide combination below the minimum level required
for positive selection. Additionally, we have shown that
M3–peptide complexes on the cell surface are more long-
lived than class Ia complexes (31). The combined effect of
limited ligand diversity and surface stability may explain the
ability of M3 to select M3-restricted T cells.
The peptides used in these experiments differed in their
ability to promote positive selection. Incubation with liste-
rial Fr38 peptide increased CD8sp development more effec-
tively than the self-derived mitochondrial peptides. Corre-
spondingly, the percentage of CD8sp cells in Fr38-treated
D71TCR-a2/2TAP2/2 lobes was, on average, greater
than that in D71TCR-a2/2 lobes (Fig. 6 A and Fig. 7).
Because the ability to bind and stabilize M3 is not signifi-
cantly different between ND1 or COI and Fr38, this sug-
gests that peptide sequence can impact M3-restricted selec-
tion. An explanation for the efficiency of Fr38 at enhancing
LemA-specific TCR selection may be provided by the na-
ture of the M3 peptide binding groove. In the crystal struc-
ture of M3, the second residue is partially exposed to the
TCR contact surface, while the side chains of residues
three and four are buried. The position five side chain
points up, and then a position six residue would be buried
(13). Fr38 and LemA share the second amino acid (Ile) and
a similar fifth residue (Ile in LemA, Leu in Fr38), whereas
ND1 and COI share phenylalanine as the second residue,
and have a fifth residue which is dissimilar to LemA (Asn
in ND1 and Arg in COI). Notably, we found that a
LemA5I®A variant with a substitution at position five is a
nonagonist (Chiu, N.M., and C.-R. Wang, unpublished
results), indicating that this residue may be an important
contact residue for the D7 TCR. However, as is the case
for class Ia–restricted selection (9, 10), sequences lacking
similarity to the antigenic peptide, i.e., ND1 and COI, are
also able to promote positive selection, although not to
wild-type levels.
Figure 8. D7 splenocytes respond to LemA and LemA6I®A, but not to
mitochondrial peptides. Splenocytes from a D71 B6 animal were incu-
bated with 10 mM of the indicated peptides at 5 3 105 cells per well in a
96-well plate. After 2 d of culture, supernatants were harvested for analy-
sis of IFN-g secretion by ELISA.1876 Thymic Selection of M3-restricted T Cells
Although M3 has 100–1,000-fold greater affinity for
N-formylated over unformylated peptides (12), a potential
role of unformylated peptide–M3 complex in thymic selec-
tion cannot be ruled out. Unformylated peptides can stim-
ulate CTLs when present at high concentrations (12).
However, even at high concentrations, unformylated pep-
tides do not stabilize M3 on the cell surface. It remains pos-
sible that some unformylated peptide(s) with low affinity
for M3 is present in such high abundance that it can con-
tribute to positive selection. Positive selection of class Ia-
restricted CD8sp thymocytes has been shown to be effective
even with low affinity self-peptides (10). We are currently
attempting to elute naturally processed self-ligand from M3
by immunoaffinity chromatography. This may provide in-
sight into the proportion of M3 molecules on the cell sur-
face, which may contain nonmitochondrial peptides.
The limitation in diversity of peptide bound to M3 has
implications for the breadth of M3’s role in selection. A di-
verse peptide supply has been shown to be important for
the restoration both of normal amounts of positive selec-
tion and of a broad repertoire of class I–restricted responses
(1, 2). This has also been shown to be the case in H-2M2/2
animals and “single peptide” MHC transgenic mice for
class II–restricted responses (44, 45). Since M3 has such a
small repertoire of self-ligands, the diversity and total num-
ber of M3-restricted T cells may be reduced as a conse-
quence. That the contribution of class Ib molecules to
positive selection has a limit is demonstrated by the re-
duced numbers of CD81 cells in KbDb double-knockout
animals (46).
It has been proposed that the selective advantage of pre-
senting numerous foreign peptides has driven the polymor-
phism of class Ia molecules, but that the mechanisms for
self-tolerance provide pressure of an opposite type. After
thymocytes rearrange the antigen receptor genes to ran-
domly generate diversity, a large proportion of thymocytes
is negatively selected. An increase in numbers of polymor-
phic class Ia molecules, while expanding the range and di-
versity of foreign peptides that can be presented, may even-
tually decrease the responding TCR repertoire by a greater
factor (47). This would occur if the range of self-peptides
presented also increases and removes an additional subset of
the TCR repertoire. A less polymorphic molecule may
evolve a specialized function, for instance, presentation of a
commonly encountered pathogenic epitope. The conser-
vation of such a sequence serves to present the pathogen
efficiently, while the limited polymorphism allows a reli-
ably small set to be removed from the T cell repertoire.
This strategy is particularly effective if the pathogenic
epitope is never, or rarely, found in the repertoire of self-
antigens. Human CD1 molecules exemplify this strategy by
presenting bacterial lipids to T cells (48, 49). M3 also fol-
lows this strategy by presenting low amounts of a small set
of self-peptides, allowing positive selection, while respond-
ing to a class of bacterial N-formylated peptide antigens
that are present in large amounts exclusively during an in-
fection. Therefore, selection of M3–restricted T cells can
serve as a model for other nonpolymorphic class Ib mole-
cules with restricted ligand specificity.
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